| GA20309-1mg |
|
— |
(Thr²)-Amyloid β-Protein (1-42)
|
0 |
C204H313N55O61S |
|
|
|
| GA20309-005mg |
|
— |
(Thr²)-Amyloid β-Protein (1-42)
|
0 |
C204H313N55O61S |
|
|
|
| GA20308-1mg |
|
2243207-05-6 |
|
0 |
C58H88N14O23 |
|
|
|
| GA20308-005mg |
|
2243207-05-6 |
|
0 |
C58H88N14O23 |
|
|
|
| GA20307-1mg |
|
1670270-09-3 |
(Thr(PO₃H₂)²³¹)-Tau Peptide (225-237)
|
0 |
C61H109N18O20P |
|
|
|
| GA20307-005mg |
|
1670270-09-3 |
(Thr(PO₃H₂)²³¹)-Tau Peptide (225-237)
|
0 |
C61H109N18O20P |
|
|
|
| GA20306-1mg |
|
215777-46-1 |
(Ser⁸)-GLP-1 (7-36) amide (human, bovine, guinea pig, mouse, rat)
|
0 |
C149H226N40O46 |
|
|
|
| GA20306-005mg |
|
215777-46-1 |
(Ser⁸)-GLP-1 (7-36) amide (human, bovine, guinea pig, mouse, rat)
|
0 |
C149H226N40O46 |
|
|
|
| GA20305-5mg |
|
550-21-0 |
|
0 |
C41H63N11O12S2 |
|
|
|
| GA20305-1mg |
|
550-21-0 |
|
0 |
C41H63N11O12S2 |
|
|
|
| GA20304-5mg |
|
184686-52-0 |
(Ser(tBu)⁶,Azagly¹⁰)-LHRH
|
0 |
C59H84N18O14 |
|
|
|
| GA20304-1mg |
|
184686-52-0 |
(Ser(tBu)⁶,Azagly¹⁰)-LHRH
|
0 |
C59H84N18O14 |
|
|
|
| GA20303-1mg |
|
— |
(Ser(PO₃H₂)⁵¹⁶)-Artemis (511-523)
|
0 |
C56H92N15O22P |
|
|
|
| GA20303-005mg |
|
— |
(Ser(PO₃H₂)⁵¹⁶)-Artemis (511-523)
|
0 |
C56H92N15O22P |
|
|
|
| GA20302-1mg |
|
2022956-60-9 |
(Ser(PO₃H₂)³⁹⁶·⁴⁰⁴)-Tau Peptide (379-408)
|
0 |
C140H230N44O52P2 |
|
|
|
| GA20302-005mg |
|
2022956-60-9 |
(Ser(PO₃H₂)³⁹⁶·⁴⁰⁴)-Tau Peptide (379-408)
|
0 |
C140H230N44O52P2 |
|
|
|
| GA20301-1mg |
|
— |
(Ser(PO₃H₂)³²³)-Hrr25 (312-323) (S. cerevisiae)
|
0 |
C43H72N15O24P |
|
|
|
| GA20301-005mg |
|
— |
(Ser(PO₃H₂)³²³)-Hrr25 (312-323) (S. cerevisiae)
|
0 |
C43H72N15O24P |
|
|
|
| GA20300-1mg |
|
— |
(Ser(PO₃H₂)²⁷³)-Nek11 (268-283)
|
0 |
C77H135N22O26PS |
|
|
|
| GA20300-005mg |
|
— |
(Ser(PO₃H₂)²⁷³)-Nek11 (268-283)
|
0 |
C77H135N22O26PS |
|
|
|
